Transferrin conjugates have shown promise in the treatment of neurodegenerative disorders, demonstrating the effectiveness of transferrin as a delivery vector for nerve growth factor (NGF) in targeting the central nervous system (CNS) and improving recognition and memory in neurodegenerative diseases [53,54]. The gene discussed is TF; the disease is neurodegenerative disease.